Psychedelics Medicinal Benefits Beyond Imagination
From claims about psilocybin reducing obesity to DMT treating eye disorders, the benefits of psychedelics are many. When the possibility of psychedelics helping humanity is thought of, a cure for cancer isn’t always the first thing that comes to mind. However, the possibilities that these substances offer will leave you surprised.
Most of the research work during the 1950s and 1960s mainly identified the use of ayahuasca, psilocybin, and other psychedelics for treating addiction. However, new findings continue to prove that this was only the tip of the iceberg, and there’s more to these psychedelic substances.
Today, psychedelic substances have shown a huge potential for treating a range of medical conditions. Some of these conditions include obesity, glaucoma, and a range of mental health conditions. This article will take you through some of the different ways psychedelics can help humanity through therapeutic and medical applications. Continue reading to find out more about these substances.
DMT as a Treatment Option for Eye Disease
PharmaDrug, a specialty pharmaceutical company, highlights that N-Dimethyltryptamine (DMT) has the potential to treat glaucoma and other eye diseases. It’s worth noting that the company partnered with Terasaki Institute for Biomedical Innovation with the aim of developing a novel drug delivery system for DMT in treating eye conditions.
Glaucoma is an eye disease that causes blindness and vision loss as a result of optic nerve damage. This condition affects a lot of people over the age of 40. Also, currently, available treatment options require multiple daily uses, and they are mostly applied to the eye, thereby causing side effects like stinging and redness. This only makes it difficult for patients to comply with these treatment options.
PharmaDrug hopes to effectively formulate a novel delivery system that can improve patient compliance.
Psilocybin to Treat Some Cancers
Psilocybin is another psychedelic substance that has shown great potential in different studies. Among this includes findings that show that it’s a promising option for cancer patients with end-of-life distress. There are also findings that show that it can help in treating a range of other types of cancers.
Even though there isn’t much research work, it’s worth noting that PharmaTher and other similar organizations are working towards the application of psilocybin for different cancer conditions.
Psilocybin for Eating Disorders and Obesity
Obesity is a disease that affects many people around the world. The Centers for Disease Control and Prevention between 2017 and 2018 highlights that over 40% of people were obese. Statistics also highlight that obesity causes other related conditions like stroke, heart disease, and type 2 diabetes.
NeonMind Biosciences, a Canadian drug development, and wellness company believe psilocybin is a great treatment option. Psilocybin acts on serotonin receptors to help control cravings and reduce appetite, thereby causing people to eat less.
In addition to showing great potential for treating over-eating, psilocybin can also be an effective option for people with other eating disorders. These disorders include bulimia nervosa, and anorexia nervosa. To date, there are no FDA-approved treatment options for anorexia nervosa. However, research to further tests the potential of psilocybin for these conditions is ongoing.
Ketamine and Treatment-Resistant Depression
Here’s another psychedelic with the potential to help humanity, especially in handling treatment-resistant depression. Even though most patients respond to conventional antidepressants, about 10 to 30% don’t show improvement. These patients eventually become suicidal and experience a higher relapse rate.
However, there are new research findings showing that ketamine can offer treatment-resistant patients significant improvement in their conditions. These studies show that clinical improvements occur within a few hours.
Today, there are many companies that are exploring the potential of ketamine to treat treatment-resistant depression.
DMT for Safer Organ Transplants
Reports from the United States Organ Procurement and Transplantation Network show that more than 100,000 Americans are on the waiting list for organ transplants. The most common challenge among these patients was ischemia-reperfusion injury.
This is a condition that occurs when there is organ tissue damage due to poor oxygen supply in the blood. The condition can affect the lung, heart, gut, brain, and kidneys. Ischemic preconditioning, machine perfusion, and ischemic post-conditioning are the common treatment approaches used. While these strategies are effective, they are technically challenging and expensive.
Interestingly, current studies show that DMT may be a great treatment option for ischemia-reperfusion injury. According to reports from different companies, DMT has anti-inflammatory protective effects, which can help reduce damages caused by ischemia-reperfusion injury during organ transplants.
Psychedelic substances continue to show great potential in handling many health conditions. We have highlighted some of these substances and the current research-based benefits they offer. Today, these substances are being explored by different research institutions to fully understand their benefits and how to incorporate these benefits into healthcare systems.